Table 1.
Target gene | Forward primer (5’-3’) | Reverse primer (5’-3’) |
---|---|---|
HMGA2 | ACCCAGGGGAAGACCCAAA | CCTCTTGGCCGTTTTTCTCCA |
ATR | GGCCAAAGGCAGTTGTATTGA | GTGAGTACCCCAAAAATAGCAGG |
Chk1 | ATATGAAGCGTGCCGTAGACT | TGCCTATGTCTGGCTCTATTCTG |
Bcl-2 | GGTGGGGTCATGTGTGTGG | CGGTTCAGGTACTCAGTCATCC |
Bax | CCCGAGAGGTCTTTTTCCGAG | CCAGCCCATGATGGTTCTGAT |
MMP-2 | TACAGGATCATTGGCTACACACC | GGTCACATCGCTCCAGACT |
MMP-9 | TGTACCGCTATGGTTACACTCG | GGCAGGGACAGTTGCTTCT |
GAPDH | GGAGCGAGATCCCTCCAAAAT | GGCTGTTGTCATACTTCTCATGG |
Notes: HMGA2, high-mobility group AT-hook 2; ATR, ATM- and Rad3-related; Chk1, checkpoint kinase 1; Bcl-2, B-cell lymphoma-2; Bax, Bcl-2 associated protein X; MMP-2, matrix metalloproteinases-2; MMP-9, matrix metalloproteinases-9; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase.